Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) is now available.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced a positive profit alert, expecting a significant increase in net profit for the year ended December 31, 2024, ranging from approximately RMB230 million to RMB260 million, compared to RMB151.5 million in the previous year. This growth is attributed to a substantial rise in sales volume of their biodegradable occluder products, driven by strategic R&D, academic promotion, and commercialization efforts, positioning the company for continued robust performance and better shareholder returns.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a company based in the People’s Republic of China, operating in the medical technology industry. The company specializes in the development and commercialization of innovative medical products, with a focus on biodegradable occluder products.
YTD Price Performance: 4.82%
Average Trading Volume: 289,482
Technical Sentiment Consensus Rating: Hold
Learn more about 2291 stock on TipRanks’ Stock Analysis page.